NY State Senate Bill 2025-S7987A

Current Bill Status - In Senate Committee Insurance Committee

Introduced
- In Committee Assembly
- In Committee Senate
- On Floor Calendar Assembly
- On Floor Calendar Senate
- Passed Assembly
- Passed Senate
Delivered to Governor
Signed By Governor

Please enter your contact information

First Name

Last Name

Email Address

A valid email address is required.

Home address is used to determine the senate district in which you reside. Your support or opposition to this bill is then shared immediately with the senator who represents you.

Optional services from the NY State Senate:

Create an account. An account allows you to officially support or oppose key legislation, sign petitions with a single click, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Include a custom message for your Senator? (Optional)

Enter a message to your senator. Many New Yorkers use this to share the reasoning behind their support or opposition to the bill. Others might share a personal anecdote about how the bill would affect them or people they care about.

Actions

View Actions

	Assembly Actions - Lowercase Senate Actions - UPPERCASE
Aug 08, 2025	print number 7987a
Aug 08, 2025	amend and recommit to insurance
May 15, 2025	referred to insurance

Bill Amendments

Original

A (Active)

2025-S7987 - Details

See Assembly Version of this Bill:: A7944
Current Committee:: Senate Insurance
Law Section:: Insurance Law
Laws Affected:: Amd §§3216, 3221 & 4303, Ins L; add §§4406-j & 2404-e, Pub Health L

2025-S7987 - Summary

Ensures continuity of care for cancer patients during insurance contract negotiations by requiring insurance coverage and treatment continue until the conclusion of care.

2025-S7987 - Sponsor Memo

                                 
BILL NUMBER: S7987

SPONSOR: MAYER
 
TITLE OF BILL:

An act to amend the insurance law and the public health law, in relation
to ensuring continuity of care for cancer patients during insurance
contract negotiations

 
PURPOSE:

This legislation will ensure that oncology patients currently being
treated for cancer will continue to receive coverage from their insurers
in the event that the insurer and oncology treatment provider fail to
agree during contract renewal negotiations. In such an event, all such
patients will be "grandfathered" under the insurer and oncology treat-
ment provider, and will remain covered by insurance and treated by such
provider, for the balance of the course of their treatment.

 
SUMMARY OF SPECIFIC PROVISIONS:

Section 1 sets forth that this act shall be know and may be cited as the

"Continuity of Cancer Care Act" or the "COCCA".ò

Section 2 amends Section 3216 of the insurance law by adding language
stating insurers must continue covering care for such treatments,
regardless of contractual disputes, until the conclusion of the
insured's care.

Section 3 amends Section 3221 of the insurance law by adding language
stating insurers must continue covering care for such treatments,
regardless of contractual disputes, until the conclusion of the
insured's care.

Section 4 amends Section 4304 of the insurance law by adding language
stating insurers must continue covering care for such treatments,
regardless of contractual disputes, until the conclusion of the
insured's care.

Section 5 amends the Public Health Law by adding a new section 2404-e
entitled Cancer; duty to continue treatment - which states insurers must
continue covering care for such treatments, regardless of contractual
disputes, until the conclusion of the insured's care.

Section 6 sets the effective date.

 
JUSTIFICATION:

Dealing with a diagnosis of cancer is difficult enough for both the
patient and their loved ones. For a patient to thereafter receive 4
44gor from their insurance provider, that their oncologists may no long-
er be considered "in network" with such insurance provider, is simply
too much to bear. Nonetheless, in October 2024, a major insurer provider
sent such a letter to tens of thousands of its insured patients, regard-
ing their contract negotiations with Memorial Sloan Kettering Cancer
Center ("MSKCC"), stating that coverage for any and all treatments would
end December 31, 2024. Soon thereafter, the insurance provider sent a
follow-up letter stating they would "grandfather" all patients, current-
ly under treatment, until March 31, 2025. Thankfully, the parties came
to an agreement. Had they not, thousands of cancer patients would have
been forced to leave MSKCC in April 2025, regardless of the status of
their treatment. This bill ensures that any patients currently under
treatment, will be automatically grandfathered for continued care until
the end of their treatment.

 
PRIOR LEGISLATIVE HISTORY:

New bill.

 
FISCAL IMPLICATIONS:

None.

 
EFFECTIVE DATE:
This act shall take effect on the ninetieth day after it shall have
become a law.

2025-S7987 - Bill Text download pdf

                             
                     S T A T E   O F   N E W   Y O R K
 ________________________________________________________________________
 
                                   7987
 
                        2025-2026 Regular Sessions
 
                             I N  S E N A T E
 
                               May 15, 2025
                                ___________
 
 Introduced  by  Sen.  MAYER  -- read twice and ordered printed, and when
   printed to be committed to the Committee on Insurance
 
 AN ACT to amend the insurance law and the public health law, in relation
   to ensuring continuity of care for cancer  patients  during  insurance
   contract negotiations

   THE  PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
 BLY, DO ENACT AS FOLLOWS:
 
   Section 1. This act shall be known and may be cited as the "Continuity
 of Cancer Care Act" or the "COCCA".
   § 2. Section 3216 of the insurance law is  amended  by  adding  a  new
 subsection (n) to read as follows:
   (N)  AN  INSURER  SHALL,  WHERE  AN INSURED IS RECEIVING TREATMENT FOR
 CANCER AT A HOSPITAL THAT SPECIALIZES IN ONCOLOGY TREATMENT  WHICH  SUCH
 INSURER  WAS  COVERING  IN  WHOLE  OR  IN PART AND SUCH INSURER AND SUCH
 HOSPITAL COMPANY CANNOT COME TO AN  AGREEMENT  DURING  CONTRACT  NEGOTI-
 ATIONS,  CONTINUE  TO  COVER  SUCH TREATMENTS FOR SUCH INSURED UNTIL THE
 CONCLUSION OF SUCH INSURED'S CARE.
   § 3. Section 3221 of the insurance law is  amended  by  adding  a  new
 subsection (v) to read as follows:
   (V)  AN  INSURER  SHALL,  WHERE  AN INSURED IS RECEIVING TREATMENT FOR
 CANCER AT A HOSPITAL THAT SPECIALIZES IN ONCOLOGY TREATMENT  WHICH  SUCH
 INSURER  WAS  COVERING  IN  WHOLE  OR  IN PART AND SUCH INSURER AND SUCH
 HOSPITAL COMPANY CANNOT COME TO AN  AGREEMENT  DURING  CONTRACT  NEGOTI-
 ATIONS,  CONTINUE  TO  COVER  SUCH TREATMENTS FOR SUCH INSURED UNTIL THE
 CONCLUSION OF SUCH INSURED'S CARE.
   § 4. Section 4303 of the insurance law is  amended  by  adding  a  new
 subsection (i) to read as follows:
   (I)  AN  INSURER  SHALL,  WHERE  AN INSURED IS RECEIVING TREATMENT FOR
 CANCER AT A HOSPITAL THAT SPECIALIZES IN ONCOLOGY TREATMENT  WHICH  SUCH
 INSURER  WAS  COVERING  IN  WHOLE  OR  IN PART AND SUCH INSURER AND SUCH
 HOSPITAL COMPANY CANNOT COME TO AN  AGREEMENT  DURING  CONTRACT  NEGOTI-
 
  EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                       [ ] is old law to be omitted.
                                                            LBD10785-01-5

 S. 7987                             2
 
 ATIONS,  CONTINUE  TO  COVER  SUCH TREATMENTS FOR SUCH INSURED UNTIL THE
 CONCLUSION OF SUCH INSURED'S CARE.
   §  5.  The public health law is amended by adding a new section 2404-e
 to read as follows:
   § 2404-E. CANCER; DUTY  TO  CONTINUE  TREATMENT.  WHERE  A  PERSON  IS
 RECEIVING TREATMENT FOR CANCER AT A HOSPITAL THAT SPECIALIZES IN ONCOLO-
 GY  TREATMENT  WHICH  IS  COVERED BY SUCH PERSON'S INSURANCE COMPANY AND
 SUCH HOSPITAL AND SUCH PERSON'S INSURANCE  COMPANY  CANNOT  COME  TO  AN
 AGREEMENT  DURING  CONTRACT NEGOTIATIONS, SUCH PERSON SHALL REMAIN UNDER
 CONTINUOUS CARE OF SUCH  HOSPITAL  AND  SUCH  PERSON'S  INSURANCE  SHALL
 CONTINUE  TO PROVIDE SUCH COVERAGE FOR SUCH TREATMENTS UNTIL THE CONCLU-
 SION OF SUCH PERSON'S CARE.
   § 6. This act shall take effect immediately.

2025-S7987A (ACTIVE) - Details

See Assembly Version of this Bill:: A7944
Current Committee:: Senate Insurance
Law Section:: Insurance Law
Laws Affected:: Amd §§3216, 3221 & 4303, Ins L; add §§4406-j & 2404-e, Pub Health L

2025-S7987A (ACTIVE) - Summary

Ensures continuity of care for cancer patients during insurance contract negotiations by requiring insurance coverage and treatment continue until the conclusion of care.

2025-S7987A (ACTIVE) - Sponsor Memo

                                 
BILL NUMBER: S7987A

SPONSOR: MAYER
 
TITLE OF BILL:

An act to amend the insurance law and the public health law, in relation
to ensuring continuity of care for cancer patients during insurance
contract negotiations

 
PURPOSE:

This legislation will ensure that oncology patients currently being
treated for cancer will continue to receive coverage from their insurers
in the event that the insurer and oncology treatment provider fail to
agree during contract renewal negotiations. In such an event, all such
patients will be "grandfathered" under the insurer and oncology treat-
ment provider, and will remain covered by insurance and treated by such
provider, for the balance of the course of their treatment.

 
SUMMARY OF SPECIFIC PROVISIONS:

Section 1 sets forth that this act shall be know and may be cited as the

"Continuity of Cancer Care Act" or the "COCCA".

Section 2 amends Section 3216 of the insurance law by adding language
stating insurers must continue covering care for such treatments,
regardless of contractual disputes, throughout the insured's course of
treatment. The bill defines course of treatment as the time period
during which the treatment protocol aimed at combatting the insured's
cancer has been fully administered and the insured is found to be clin-
ically stable. The course of treatment also covers any follow-up
appointments within 90 days of when the insured is clinically stable.
Additionally, the section provides that insurance companies must contin-
ue to cover treatments at the rate payable under the prior contract, and
that such rate will be adjusted at the beginning of the next calendar
year by the applicable Medicaid Economic Index minus one percentage
point.

Section 3 amends Section 3221 of the insurance law by adding language
stating insurers must continue covering care for such treatments,
regardless of contractual disputes, until the conclusion of the
insured's care.

Section 4 amends Section 4304 of the insurance law by adding language
stating insurers must continue covering care for such treatments,
regardless of contractual disputes, until the conclusion of the
insured's care.

Section 5 amends the Public Health Law by adding a new section 2404-e
entitled Cancer; duty to continue treatment - which states insurers must
continue covering care for such treatments, regardless of contractual
disputes, until the conclusion of the insured's care.

Section 6 sets the effective date.

 
JUSTIFICATION:

Dealing with a diagnosis of cancer is difficult enough for both the
patient and their loved ones. For a patient to thereafter receive a
letter from their insurance provider, that their oncologists may no
longer be considered "in network" with such insurance provider, is
simply too much to bear. Nonetheless, in October 2024, a major insurer
provider sent such a letter to tens of thousands of its insured
patients, regarding their contract negotiations with Memorial Sloan
Kettering Cancer Center ("MSKCC"), stating that coverage for any and all
treatments would end December 31, 2024. Soon thereafter, the insurance
provider sent a follow-up letter stating they would "grandfather" all
patients, currently under treatment, until March 31, 2025. Thankfully,
the parties came to an agreement. Had they not, thousands of cancer
patients would have been forced to leave MSKCC in April 2025, regardless
of the status of their treatment. This bill ensures that any patients
currently under treatment, will be automatically grandfathered for
continued care until the end of their treatment.

 
PRIOR LEGISLATIVE HISTORY:

New bill.

 
FISCAL IMPLICATIONS:

None.

 
EFFECTIVE DATE:
This act shall take effect immediately.

2025-S7987A (ACTIVE) - Bill Text download pdf

                             
                     S T A T E   O F   N E W   Y O R K
 ________________________________________________________________________
 
                                  7987--A
 
                        2025-2026 Regular Sessions
 
                             I N  S E N A T E
 
                               May 15, 2025
                                ___________
 
 Introduced  by  Sen.  MAYER  -- read twice and ordered printed, and when
   printed to be committed to the Committee  on  Insurance  --  committee
   discharged, bill amended, ordered reprinted as amended and recommitted
   to said committee
 
 AN ACT to amend the insurance law and the public health law, in relation
   to  ensuring  continuity  of care for cancer patients during insurance
   contract negotiations
 
   THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND  ASSEM-
 BLY, DO ENACT AS FOLLOWS:
 
   Section 1. This act shall be known and may be cited as the "Continuity
 of Cancer Care Act" or the "COCCA".
   §  2.  Section  3216  of  the insurance law is amended by adding a new
 subsection (n) to read as follows:
   (N) (1) FOR THE PURPOSE OF THIS SUBSECTION:
   (A) "COURSE OF TREATMENT" SHALL MEAN THAT THE TREATMENT PROTOCOL AIMED
 AT COMBATING THE INSURED'S CANCER HAS BEEN ADMINISTERED AND THE  INSURED
 IS  CLINICALLY  STABLE. ADDITIONALLY, FOLLOW-UP APPOINTMENTS/CARE FOR UP
 TO NINETY DAYS AFTER THE INSURED IS FOUND TO BE CLINICALLY STABLE  SHALL
 ALSO BE CONSIDERED PART OF THE INSURED'S COURSE OF TREATMENT.
   (B)  "CLINICAL STABILITY" SHALL MEAN NINETY DAYS HAVE PASSED SINCE THE
 TREATMENT HAS BEEN FULLY ADMINISTERED AND: (I)  THE  INSURED  SHOWS  THE
 INTENDED RESULT FROM THEIR TREATMENT PROTOCOL WITHOUT COMPLICATIONS THAT
 WOULD  REQUIRE  ONGOING MANAGEMENT BY THE PROVIDER'S PHYSICIANS; OR (II)
 THE INSURED IS RECEIVING MAINTENANCE TREATMENT  TO  CONTROL  THE  CANCER
 FROM REOCCURRING.
   (2)  AN  INSURER  SHALL,  WHERE  AN INSURED IS RECEIVING TREATMENT FOR
 CANCER AT A  HOSPITAL,  DOCTOR'S  OFFICE  OR  ANY  OTHER  PROVIDER  THAT
 PROVIDES  ONCOLOGY TREATMENT WHICH SUCH INSURER WAS COVERING IN WHOLE OR
 IN PART AND SUCH INSURER AND SUCH PROVIDER CANNOT COME TO  AN  AGREEMENT
 DURING  CONTRACT NEGOTIATIONS, CONTINUE TO COVER SUCH TREATMENTS, AT THE
 RATE PAYABLE UNDER THE  PRIOR  CONTRACT,  FOR  SUCH  INSURED  UNTIL  THE
 
  EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                       [ ] is old law to be omitted.
                                                            LBD10785-03-5

 S. 7987--A                          2
 
 CONCLUSION OF SUCH INSURED'S ENTIRE COURSE OF TREATMENT AND THE INDIVID-
 UAL  IS  FOUND  TO  BE CLINICALLY STABLE, PROVIDED THAT THE RATE PAYABLE
 UNDER THE PRIOR CONTRACT SHALL BE ADJUSTED BY  THE  APPLICABLE  MEDICARE
 ECONOMIC  INDEX  MINUS  ONE PERCENTAGE POINT APPLIED TO PAYMENT RATES AT
 THE START OF THE NEXT CALENDAR YEAR, AND FOR  EACH  SUCCEEDING  CALENDAR
 YEAR,  FOR INDIVIDUALS THAT ARE CONTINUING TO RECEIVE TREATMENT PURSUANT
 TO THIS PROVISION.
   § 3. Section 3221 of the insurance law is  amended  by  adding  a  new
 subsection (v) to read as follows:
   (V) (1) FOR THE PURPOSE OF THIS SUBSECTION:
   (A) "COURSE OF TREATMENT" SHALL MEAN THAT THE TREATMENT PROTOCOL AIMED
 AT  COMBATING THE INSURED'S CANCER HAS BEEN ADMINISTERED AND THE INSURED
 IS CLINICALLY STABLE. ADDITIONALLY, FOLLOW-UP APPOINTMENTS/CARE  FOR  UP
 TO  NINETY DAYS AFTER THE INSURED IS FOUND TO BE CLINICALLY STABLE SHALL
 ALSO BE CONSIDERED PART OF THE INSURED'S COURSE OF TREATMENT.
   (B) "CLINICAL STABILITY" SHALL MEAN NINETY DAYS HAVE PASSED SINCE  THE
 TREATMENT  HAS  BEEN  FULLY  ADMINISTERED AND: (I) THE INSURED SHOWS THE
 INTENDED RESULT FROM THEIR TREATMENT PROTOCOL WITHOUT COMPLICATIONS THAT
 WOULD REQUIRE ONGOING MANAGEMENT BY THE PROVIDER'S PHYSICIANS;  OR  (II)
 THE  INSURED  IS  RECEIVING  MAINTENANCE TREATMENT TO CONTROL THE CANCER
 FROM REOCCURRING.
   (2) AN INSURER SHALL, WHERE AN  INSURED  IS  RECEIVING  TREATMENT  FOR
 CANCER  AT  A  HOSPITAL,  DOCTOR'S  OFFICE  OR  ANY  OTHER PROVIDER THAT
 PROVIDES ONCOLOGY TREATMENT WHICH SUCH INSURER WAS COVERING IN WHOLE  OR
 IN  PART  AND SUCH INSURER AND SUCH PROVIDER CANNOT COME TO AN AGREEMENT
 DURING CONTRACT NEGOTIATIONS, CONTINUE TO COVER SUCH TREATMENTS, AT  THE
 RATE  PAYABLE  UNDER  THE  PRIOR  CONTRACT,  FOR  SUCH INSURED UNTIL THE
 CONCLUSION OF SUCH INSURED'S ENTIRE COURSE OF TREATMENT AND THE INDIVID-
 UAL IS FOUND TO BE CLINICALLY STABLE, PROVIDED  THAT  THE  RATE  PAYABLE
 UNDER  THE  PRIOR  CONTRACT SHALL BE ADJUSTED BY THE APPLICABLE MEDICARE
 ECONOMIC INDEX MINUS ONE PERCENTAGE POINT APPLIED TO  PAYMENT  RATES  AT
 THE  START  OF  THE NEXT CALENDAR YEAR, AND FOR EACH SUCCEEDING CALENDAR
 YEAR, FOR INDIVIDUALS THAT ARE CONTINUING TO RECEIVE TREATMENT  PURSUANT
 TO THIS PROVISION.
   §  4.  Section  4303  of  the insurance law is amended by adding a new
 subsection (i) to read as follows:
   (I) (1) FOR THE PURPOSE OF THIS SUBSECTION:
   (A) "COURSE OF TREATMENT" SHALL MEAN THAT THE TREATMENT PROTOCOL AIMED
 AT COMBATING THE INSURED'S CANCER HAS BEEN ADMINISTERED AND THE  INSURED
 IS  CLINICALLY  STABLE. ADDITIONALLY, FOLLOW-UP APPOINTMENTS/CARE FOR UP
 TO NINETY DAYS AFTER THE INSURED IS FOUND TO BE CLINICALLY STABLE  SHALL
 ALSO BE CONSIDERED PART OF THE INSURED'S COURSE OF TREATMENT.
   (B)  "CLINICAL STABILITY" SHALL MEAN NINETY DAYS HAVE PASSED SINCE THE
 TREATMENT HAS BEEN FULLY ADMINISTERED AND: (I)  THE  INSURED  SHOWS  THE
 INTENDED RESULT FROM THEIR TREATMENT PROTOCOL WITHOUT COMPLICATIONS THAT
 WOULD  REQUIRE  ONGOING MANAGEMENT BY THE PROVIDER'S PHYSICIANS; OR (II)
 THE INSURED IS RECEIVING MAINTENANCE TREATMENT  TO  CONTROL  THE  CANCER
 FROM REOCCURRING.
   (2)  AN  INSURER  SHALL,  WHERE  AN INSURED IS RECEIVING TREATMENT FOR
 CANCER AT A  HOSPITAL,  DOCTOR'S  OFFICE  OR  ANY  OTHER  PROVIDER  THAT
 PROVIDES  ONCOLOGY TREATMENT WHICH SUCH INSURER WAS COVERING IN WHOLE OR
 IN PART AND SUCH INSURER AND SUCH PROVIDER CANNOT COME TO  AN  AGREEMENT
 DURING  CONTRACT NEGOTIATIONS, CONTINUE TO COVER SUCH TREATMENTS, AT THE
 RATE PAYABLE UNDER THE PREVIOUS CONTRACT, FOR  SUCH  INSURED  UNTIL  THE
 CONCLUSION  OF SUCH INSURED'S ENTIRE COURSE OF TREATMENT AND THE INSURED
 IS FOUND TO BE CLINICALLY STABLE, PROVIDED THAT THE RATE  PAYABLE  UNDER
 S. 7987--A                          3
 
 THE PRIOR CONTRACT SHALL BE ADJUSTED BY THE APPLICABLE MEDICARE ECONOMIC
 INDEX  MINUS  ONE PERCENTAGE POINT APPLIED TO PAYMENT RATES AT THE START
 OF THE NEXT CALENDAR YEAR, AND FOR EACH SUCCEEDING  CALENDAR  YEAR,  FOR
 INDIVIDUALS  THAT  ARE  CONTINUING TO RECEIVE TREATMENT PURSUANT TO THIS
 PROVISION.
   § 5. The public health law is amended by adding a new  section  4406-j
 to read as follows:
   §  4406-J.  CONTINUITY  OF  CANCER  CARE.  1.  FOR THE PURPOSE OF THIS
 SECTION:
   (A) "COURSE OF TREATMENT" SHALL MEAN THAT THE TREATMENT PROTOCOL AIMED
 AT COMBATING THE INSURED'S CANCER HAS BEEN ADMINISTERED AND THE  INSURED
 IS  CLINICALLY  STABLE. ADDITIONALLY, FOLLOW-UP APPOINTMENTS/CARE FOR UP
 TO NINETY DAYS AFTER THE INSURED IS FOUND TO BE CLINICALLY STABLE  SHALL
 ALSO BE CONSIDERED PART OF THE INSURED'S COURSE OF TREATMENT.
   (B)  "CLINICAL STABILITY" SHALL MEAN NINETY DAYS HAVE PASSED SINCE THE
 TREATMENT HAS BEEN FULLY ADMINISTERED AND: (I)  THE  INSURED  SHOWS  THE
 INTENDED RESULT FROM THEIR TREATMENT PROTOCOL WITHOUT COMPLICATIONS THAT
 WOULD  REQUIRE  ONGOING MANAGEMENT BY THE PROVIDER'S PHYSICIANS; OR (II)
 THE INSURED IS RECEIVING MAINTENANCE TREATMENT  TO  CONTROL  THE  CANCER
 FROM REOCCURRING.
   2.  AN ORGANIZATION SHALL, WHERE AN  INSURED  IS  RECEIVING  TREATMENT
 FOR CANCER AT A HOSPITAL, DOCTOR'S OFFICE OR  ANY  OTHER  PROVIDER  THAT
 PROVIDES  ONCOLOGY  TREATMENT  WHICH  SUCH  ORGANIZATION WAS COVERING IN
 WHOLE OR IN PART AND  SUCH  ORGANIZATION   AND   SUCH PROVIDER    CANNOT
 COME  TO  AN  AGREEMENT  DURING CONTRACT NEGOTIATIONS, CONTINUE TO COVER
 SUCH TREATMENTS, AT THE RATE PAYABLE UNDER THE PRIOR CONTRACT, FOR  SUCH
 INSURED  UNTIL THE CONCLUSION OF SUCH INSURED'S ENTIRE COURSE OF  TREAT-
 MENT  AND THE INDIVIDUAL IS FOUND TO BE CLINICALLY STABLE, PROVIDED THAT
 THE RATE PAYABLE UNDER THE PRIOR  CONTRACT  SHALL  BE  ADJUSTED  BY  THE
 APPLICABLE MEDICARE ECONOMIC INDEX MINUS ONE PERCENTAGE POINT APPLIED TO
 PAYMENT  RATES  AT  THE  START  OF  THE NEXT CALENDAR YEAR, AND FOR EACH
 SUCCEEDING CALENDAR YEAR, FOR INDIVIDUALS THAT ARE CONTINUING TO RECEIVE
 TREATMENT PURSUANT TO THIS PROVISION.
   § 6. The public health law is amended by adding a new  section  2404-e
 to read as follows:
   §  2404-E.  CANCER;  DUTY TO CONTINUE TREATMENT. 1. FOR THE PURPOSE OF
 THIS SECTION:
   (A) "COURSE OF TREATMENT" SHALL MEAN THAT THE TREATMENT PROTOCOL AIMED
 AT COMBATING THE INSURED'S CANCER HAS BEEN ADMINISTERED AND THE  INSURED
 IS  CLINICALLY  STABLE. ADDITIONALLY, FOLLOW-UP APPOINTMENTS/CARE FOR UP
 TO NINETY DAYS AFTER THE INSURED IS FOUND TO BE CLINICALLY STABLE  SHALL
 ALSO BE CONSIDERED PART OF THE INSURED'S COURSE OF TREATMENT.
   (B)  "CLINICAL STABILITY" SHALL MEAN NINETY DAYS HAVE PASSED SINCE THE
 TREATMENT HAS BEEN FULLY ADMINISTERED AND: (I)  THE  INSURED  SHOWS  THE
 INTENDED RESULT FROM THEIR TREATMENT PROTOCOL WITHOUT COMPLICATIONS THAT
 WOULD  REQUIRE  ONGOING MANAGEMENT BY THE PROVIDER'S PHYSICIANS; OR (II)
 THE INSURED IS RECEIVING MAINTENANCE TREATMENT  TO  CONTROL  THE  CANCER
 FROM REOCCURRING.
   2.  WHERE  A  PERSON  IS RECEIVING TREATMENT FOR CANCER AT A HOSPITAL,
 DOCTOR'S OFFICE OR ANY OTHER PROVIDER THAT PROVIDES  ONCOLOGY  TREATMENT
 WHICH  IS  COVERED  BY SUCH PERSON'S INSURANCE COMPANY AND SUCH PROVIDER
 AND SUCH PERSON'S INSURANCE COMPANY CANNOT COME TO AN  AGREEMENT  DURING
 CONTRACT NEGOTIATIONS, SUCH PERSON SHALL REMAIN UNDER CONTINUOUS CARE OF
 SUCH PROVIDER AND SUCH PERSON'S INSURANCE SHALL CONTINUE TO PROVIDE SUCH
 COVERAGE  FOR  SUCH  TREATMENTS,  AT  THE  RATE  PAYABLE UNDER THE PRIOR
 CONTRACT, UNTIL THE CONCLUSION OF SUCH PERSON'S ENTIRE COURSE OF  TREAT-
 S. 7987--A                          4
 
 MENT AND THE INSURED IS FOUND TO BE CLINICALLY STABLE, PROVIDED THAT THE
 RATE  PAYABLE UNDER THE PRIOR CONTRACT SHALL BE ADJUSTED BY THE APPLICA-
 BLE MEDICARE ECONOMIC  INDEX  MINUS  ONE  PERCENTAGE  POINT  APPLIED  TO
 PAYMENT  RATES  AT  THE  START  OF  THE NEXT CALENDAR YEAR, AND FOR EACH
 SUCCEEDING CALENDAR YEAR, FOR INDIVIDUALS THAT ARE CONTINUING TO RECEIVE
 TREATMENT PURSUANT TO THIS PROVISION.
   § 7. This act shall take effect immediately.

Comments

Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.

Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.

Create an account. An account allows you to sign petitions with a single click, officially support or oppose key legislation, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Senate Bill S7987A

Sponsored By

Current Bill Status - In Senate Committee Insurance Committee

Bill Amendments

2025-S7987 - Details

2025-S7987 - Summary

2025-S7987 - Sponsor Memo

2025-S7987 - Bill Text download pdf

2025-S7987A (ACTIVE) - Details

2025-S7987A (ACTIVE) - Summary

2025-S7987A (ACTIVE) - Sponsor Memo

2025-S7987A (ACTIVE) - Bill Text download pdf

Comments

Senate Bill S7987A

Share this bill

Sponsored By

Shelley B. Mayer

Current Bill Status - In Senate Committee Insurance Committee

Bill Amendments

2025-S7987 - Details

2025-S7987 - Summary

2025-S7987 - Sponsor Memo

2025-S7987 - Bill Text download pdf

2025-S7987A (ACTIVE) - Details

2025-S7987A (ACTIVE) - Summary

2025-S7987A (ACTIVE) - Sponsor Memo

2025-S7987A (ACTIVE) - Bill Text download pdf

Comments